株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

呼吸器疾患検査の世界市場:2015〜2019年

Global Respiratory Disease Testing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 345192
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
呼吸器疾患検査の世界市場:2015〜2019年 Global Respiratory Disease Testing Market 2015-2019
出版日: 2015年11月11日 ページ情報: 英文 66 Pages
概要

世界的に、喘息やCOPDなどの呼吸器疾患の発症率は上昇しています。およそ2億3,500万人が喘息を患い、COPDのために世界で300万人が死亡しています。世界の呼吸器疾患検査市場は2014〜2019年にかけCAGR7.46%で拡大すると予測されています。

当レポートでは、世界の呼吸器疾患検査市場について調査し、地域別動向、今後の市場成長見込み、2019年の市場規模予測、市場成長の課題、主要ベンダーの動向などをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市場環境

  • 市場概要
  • ファイブフォース分析

第6章 検査別市場セグメンテーション

第7章 機械・スクリーニング検査別市場セグメンテーション

第8章 IVD検査別市場セグメンテーション

第9章 地域別セグメンテーション

第10章 市場促進因子

  • 慢性呼吸器疾患の蔓延
  • 大気汚染の増加
  • タバコ消費量の増加
  • 医療サービス改善に向けた政府の取組み

第11章 促進因子の影響

第12章 市場の課題

  • 費用対効果の高い製品の使用
  • 製品設計中の生体適合性の問題
  • 標準的処置と資金の不足
  • 価格の天井による圧力

第13章 促進因子と課題の影響

第14章 市場動向

  • 認識拡大のためのイニシアティブとプログラム
  • 複合装置の使用
  • ポータブル装置
  • POC装置の人気

第15章 ベンダー環境

  • 競合シナリオ
  • 注目のベンダー
  • その他の注目すべきベンダー

第16章 主要ベンダー分析

  • Alere
  • CareFusion
  • 日本光電工業株式会社
  • Philips Healthcare
  • Smiths Medical

第17章 付録

第18章 Techvavioについて

図表

目次
Product Code: IRTNTR7885

About respiratory disease testing

The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages.

Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption.

These factors result in increased demand for the respiratory testing devices and propel the market growth.

Technavio's analysts forecast the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases.

The market is segmented based on the type of test:

  • Mechanical/screening tests
  • Spirometry test
  • Peak flow test
  • Blood gas test
  • Lung volume test
  • OSA diagnostic tests
  • IVD tests
  • Molecular diagnostic test
  • POC test
  • Others

Technavio's report, Global Respiratory Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Alere
  • CareFusion
  • Nihon Kohden
  • Philips Healthcare
  • Smiths Medical

Other Prominent Vendors

  • Abbott
  • Affymetrix
  • Cepheid
  • COSMED
  • Covidien
  • F. Hoffmann-La Roche
  • Futuremed America
  • Instrumentation Laboratories
  • ndd Medical Technology
  • SDI Diagnostics
  • Seegene
  • Siemens Healthcare

Key market driver

  • Increase in respiratory disorders worldwide
  • For a full, detailed list, view our report

Key market challenge

  • Use of low-cost testing products
  • For a full, detailed list, view our report

Key market trend

  • Initiatives and programs to create awareness
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by test

PART 07: Market segmentation by mechanical and screening test

  • Market size and forecast

PART 08: Market segmentation by IVD test

  • Molecular diagnostic tests
  • POC tests
  • Other tests

PART 09: Geographical segmentation

  • Global respiratory testing market segmentation by geography

PART 10: Market drivers

  • Prevalence of chronic respiratory diseases
  • Rise in air pollution
  • Increased consumption of tobacco
  • Government measures for improving healthcare services

PART 11: Impact of drivers

PART 12: Market challenges

  • Use of cost-effective products
  • Biocompatibility complications during product design
  • Lack of standard procedure and funds
  • Pricing pressure through price ceilings

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Initiatives and programs to spread awareness
  • Use of multiplex devices
  • Preference for portable devices
  • Popularity of POC devices

PART 15: Vendor landscape

  • Competitive scenario
  • Key prominent vendors
  • Other prominent vendors

PART 16: Key vendor analysis

  • Alere
  • CareFusion
  • Nihon Kohden
  • Philips Healthcare
  • Smiths Medical

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Overview of global respiratory disease testing market
  • Exhibit 03: Global respiratory disease testing market 2014-2019 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global respiratory disease testing market by test
  • Exhibit 06: Global respiratory disease testing market by test type 2014
  • Exhibit 07: Global respiratory disease testing market by mechanical and screening test 2014-2019 ($ billions)
  • Exhibit 08: Global respiratory disease testing market by spirometry 2014-2019 ($ millions)
  • Exhibit 09: Global respiratory disease testing market by peak flow test 2014-2019 ($ millions)
  • Exhibit 10: Global respiratory disease testing market by blood gas test 2014-2019 ($ millions)
  • Exhibit 11: Global respiratory disease testing market by pulmonary function test 2014-2019 ($ millions)
  • Exhibit 12: Global respiratory disease testing market by OSA diagnostic test 2014-2019 ($ millions)
  • Exhibit 13: Global respiratory disease testing market by IVD test 2014
  • Exhibit 14: Global respiratory disease testing market segmentation by geography 2014
  • Exhibit 15: Respiratory disease testing market in Americas 2014-2019 ($ billions)
  • Exhibit 16: Respiratory disease testing market in EMEA 2014-2019 ($ billions)
  • Exhibit 17: Respiratory disease testing market in APAC 2014-2019 ($ billions)
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Alere: Key takeaways
  • Exhibit 21: CareFusion: Key takeaways
  • Exhibit 22: Nihon Kohden: Key takeaways
  • Exhibit 23: Philips Healthcare: Key takeaways
  • Exhibit 24: Smiths Medical: Key takeaways
  • Exhibit 25: Alere: Business segmentation by revenue 2014
  • Exhibit 26: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 27: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 28: Nihon Kohden: Business segmentation by revenue 2015
  • Exhibit 29: Nihon Kohden: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 30: Nihon Kohden: Geographical segmentation by revenue 2015
  • Exhibit 31: Philips Healthcare: Business segmentation by revenue 2014
  • Exhibit 32: Smiths Medical: Business segmentation by revenue 2014
  • Exhibit 33: Smiths Medical: Business segmentation by revenue 2013 and 2014 ($ billions)
Back to Top